The $300m venture financing of Biofourmis was the Medical devices industry’s top venture financing deal as total deals worth $1.7bn were announced globally in April 2022, according to GlobalData’s deals database.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all
  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 28.9% over the previous month of $2.32bn and a drop of 35.8% when compared with the last 12-month average, which stood at $2.57bn.

Comparing venture financing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $1.27bn. At the country level, the US topped the list in terms of deal value at $1.24bn.

In terms of volumes, North America emerged as the top region for Medical devices industry venture financing deals globally, followed by Asia-Pacific and then Europe.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The top country in terms of venture financing deals activity in April 2022 was the US with 61 deals, followed by the China with 21 and the UK with five.

In 2022, as of April, Medical devices venture financing deals worth $8.77bn were announced globally, marking an increase of 13.7% year on year.

Medical devices industry venture financing deals in April 2022: Top deals

The top five Medical devices industry venture financing deals accounted for 50.9% of the overall value during April 2022.

The combined value of the top five Medical devices venture financing deals stood at $840m, against the overall value of $1.7bn recorded for the month.

The top five Medical devices industry venture financing deals of April 2022 tracked by GlobalData were:

1) CVS Health,Export Development Bank of Iran,General Atlantic,Mass Mutual Ventures,Openspace Ventures,Sequoia Capital and SoftBank Vision Fund II $300m venture financing deal with Biofourmis

2) The $220m venture financing of Reify Health by Adams Street Partners,Altimeter Capital Management,Battery Ventures,Coatue,Dragoneer Investment Group and ICONIQ Growth

3) Impact Investment Partners,Japan Industrial Partners and NEC $150m venture financing deal with BostonGene

4) The $100m venture financing of Viz.ai by Charles River Ventures,GV Management Co,Insight Partners,Kleiner Perkins,Scale Ventures,Sozo Ventures,Susa Ventures,Threshold Ventures and Tiger Global Management

5) Globis Capital Partners &,Incubate Fund,SoftBank Vision Fund 2 and World Innovation Lab (WiL fund) $70m venture financing deal with AI Medical Service